Course curriculum
-
-
Acute bacterial prostatitis (March 2021)
-
Acute bacterial sinusitis - 2Qs (March 2023)
-
Acute bronchitis (September 2022)
-
Acute epiglottitis (November 2022)
-
Anosmia - 2Qs (May 2022)
-
Antibiotic interactions - 3Qs (September 2018)
-
Asymptomatic bacteriuria - 2Qs (November 2020)
-
Autoimmune hepatitis (January 2019)
-
Bacterial vaginosis (May 2021)
-
Bat exposure (November 2019)
-
Blepharitis (January 2023)
-
Blood transfusions and COVID (March 2022)
-
Breastfeeding contraindications - 2Qs (January 2023)
-
Cat scratch disease (September 2019)
-
Cervical cancer screening - 2Qs (September 2018)
-
Chagas disease - 2Qs (March 2019)
-
Chlamydia in the newborn (January 2020)
-
Chlamydia trachomatis infection - 3Qs (January 2022)
-
Choosing Wisely (March 2023)
-
Chorioamnionitis (September 2021)
-
Clinical decision-making - febrile illness -9Qs (March 2023)
-
Clostridioides difficile infection (September 2023)
-
Clostridioides difficile - 3Qs (November 2021)
-
Clostridium difficile in children (November 2018)
-
Clostridium difficile - overview - 2Qs (November 2018)
-
Clostridium difficile - treatment -2Qs (September 2018)
-
Common cold - Prevention (September 2018)
-
Common cold - treatment (January 2022)
-
Common cold - treatment (September 2022)
-
Common variable immunodeficiency (March 2022)
-
Community-acquired pneumonia - 2Qs (March 2022)
-
Community-acquired pneumonia in adults - outpatient - 2Qs (January 2020)
-
Community acquired pneumonia in children - 2Qs (January 2023)
-
Community-acquired pneumonia - inpatient - 2Qs (January 2020)
-
Complications after splenectomy (March 2022)
-
Coronavirus - 2Qs (March 2020)
-
Condyloma acuminata - 2Qs (November 2018)
-
Condyloma acuminata in pregnancy (July 2022)
-
Condyloma acuminata - treatment - 2Qs (July 2022) - UPDATED
-
Congenital syphilis - 3Qs (January 2023)
-
Cough - postinfectious (January 2019)
-
COVID - oral treatment - 2Qs (September 2023)
-
COVID-19 - oral treatment (May 2022)
-
Coxsackievirus (November 2018)
-
Croup - 2Qs (January 2023)
-
Cytomegalovirus - 2Qs (May 2021)
-
Dengue - 2Qs (May 2023)
-
Dengue - 2Qs (July 2020)
-
Dermatologic manifestations of COVID-19 - 3Qs (September 2020)
-
Diabetic foot osteomyelitis - 3Qs (May 2020)
-
Disseminated gonococcal infection - 2Qs (November 2021)
-
Diverticulitis - 4Qs (January 2022)
-
Dog and cat bites - 3Qs (May 2019)
-
Dyspepsia - 2Qs (September 2021)
-
Dysphonia - 3Qs (May 2022)
-
Ebola - 3Qs (January 2022)
-
Ehrlichiosis - 2Qs (May 2022)
-
Endocarditis prophylaxis (January 2023)
-
Enteric fever (Typhoid and Paratyphoid) - 2Qs (November 2020)
-
Enterovirus D68 (May 2020)
-
Eosinophilia - 2Qs (May 2020)
-
Epididymitis - 3Qs (May 2021)
-
Erysipelas (September 2021)
-
Esophageal disorders - 3Qs (November 2019)
-
Extrapulmonary tuberculosis - 3Qs (November 2022)
-
Fluoroquinolones - adverse effects (July 2019)
-
Fluoroquinolones - adverse effects - 2Qs (November 2018)
-
Food poisoning - 5Qs (July 2020)
-
Gastric cancer (July 2022)
-
Gastroenteritis - Pediatric - 3Qs (May 2020)
-
Gastroparesis - 3Qs (January 2023)
-
Gonorrhea - 3Qs (November 2021)
-
Group B strep - early onset disease - 2Qs (January 2020)
-
Group B strep - late onset disease (January 2020)
-
Group B strep screening and prophylaxis - 3Qs (January 2020)
-
H. pylori - diagnosis - 2Qs (July 2022)
-
Handwashing (November 2021)
-
Handwashing (May 2019)
-
Head lice (March 2022)
-
Head lice (September 2019)
-
Helicobacter pylori - 2Qs (November 2019)
-
Hematospermia - 2Qs (May 2020)
-
Hepatitis A pre- and post-exposure prophylaxis - 2Qs (January 2021)
-
Hepatitis A - 2Qs (May 2020)
-
Hepatitis A - pre- and post-exposure prophylaxis - 2Qs (March 2019)
-
Hepatitis A vaccination - 2Qs (March 2019)
-
Hepatitis B virus screening and vaccination - 2Qs (July 2018)
-
Hepatitis C exposure and healthcare personnel (January 2021)
-
Hepatitis C and renal disease - 2Qs (September 2022)
-
Hepatitis C - screening - 2Qs (July 2020)
-
Hepatitis C testing in pregnancy - 3Qs (July 2020)
-
Hepatitis C treatment - 2Qs (January 2021)
-
Hepatitis E - 2Qs (May 2022)
-
Herpes in pregnancy (March 2019)
-
Herpes simplex virus (HSV) in pregnancy - 3Qs (September 2020)
-
Herpes zoster - 2Qs (November 2022)
-
Herpes zoster opthalmicus (September 2021)
-
Herpetic Esophagitis - 3Qs (November 2019)
-
Herpes simplex infection and pregnancy - 2Qs (January 2023)
-
Herpes zoster - 3Qs (November 2021)
-
Herpes zoster -2Qs (November 2018)
-
High-grade cervical squamous intraepithelial lesion (July 2018)
-
HIV and breastfeeding (March 2020)
-
HIV and cardiovascular disease -2Qs (January 2020)
-
HIV during pregnancy and in infants - 2Qs (March 2020)
-
HIV in older adults (March 2020)
-
HIV screening (November 2021)
-
Hot tub folliculitis (September 2020)
-
HPV infection counseling (July 2022)
-
HPV-related cancers - 3Qs (November 2021)
-
HPV - Vaccines and Indications - 2Qs (November 2020)
-
Human bites (May 2021)
-
Human bite injuries - 2Qs (July 2019)
-
Human metapneumovirus (January 2020)
-
Human papilloma virus vaccine update - 3Qs (March 2019)
-
Immunizations and adults with HIV - 2Qs (September 2019)
-
Immunizations and children with HIV (September 2019)
-
Infants and HIV exposure - 2Qs (March 2020)
-
Infections and cardiovascular disease -2Qs (January 2021)
-
Infection of cardiac implantable electronic devices - 2Qs (January 2023)
-
Infectious mononucleosis (January 2022)
-
Infectious mononucleosis (January 2020)
-
Influenza diagnosis (July 2019)
-
Influenza in high risk populations - 3Qs (May 2020)
-
Influenza in long-term care facilities - 2Qs (May 2020)
-
Influenza prevention (March 2022)
-
Influenza - prevention and treatment (November 2022)
-
Influenza testing (March 2022)
-
Influenza treatment and prophylaxis - 2Qs (March 2022)
-
Interferon gamma release assay for TB - 3Qs (September 2020)
-
Invasive meningococcal disease - chemoprophylaxis (November 2018)
-
Latent syphilis - 2Qs (November 2021)
-
Latent tuberculosis - 2Qs (March 2019)
-
Legionella - 2Qs (November 2020)
-
Leptospirosis (July 2020)
-
Leptospirosis (March 2019)
-
Lung abscess (September 2022)
-
Lyme disease - 2Qs (May 2021)
-
Lyme disease - cutaneous - 2Qs (May 2021)
-
Lyme - Noncutaneous - 3Qs (May 2021)
-
Malaria - diagnosis (May 2022)
-
Malaria prophylaxis - 2Qs (March 2022)
-
Management of neonates exposed to HSV - 2Qs (September 2020)
-
Measles (September 2020)
-
Measles - 2Qs (November 2018)
-
Meningococcal ACWY vaccines - 2Qs (November 2018)
-
Meningococcal type B vaccine (November 2018)
-
Molluscum contagiosum - 2Qs (March 2019)
-
Monkeypox - 4Qs (September 2023)
-
Mycobacterium Avium Complex - 2Qs (July 2019)
-
Myocarditis - 2Qs (March 2021)
-
Necrotizing soft tissue infection (March 2022)
-
Needlestick injuries - 3Qs (November 2021)
-
Neonatal gonococcal infection (November 2021)
-
Neonatal herpes simplex virus (HSV) -2Qs (September 2020)
-
Neonatal sepsis (July 2021)
-
Neuraminidase inhibitors for influenza -3Qs (May 2023)
-
Orbital cellulitis - 2Qs (September 2022)
-
Orbital cellulitis - 2Qs (July 2021)
-
Oropharyngeal Candidiasis (July 2019)
-
Osteomyelitis - 3Qs (May 2019)
-
Pediatric limp - 3Qs (January 2019)
-
Pelvic inflammatory disease - 3Qs (March 2022)
-
Pelvic inflammatory disease - 3Qs (November 2021)
-
Pericarditis - Acute - 2Qs (September 2018)
-
Perinatal Group B Streptococcus - prevention - 3Qs (November 2018)
-
Pertussis - 4Qs (January 2021)
-
Pilonidal disease - 2Qs (September 2022)
-
Pneumococcal disease - Prevention (July 2022)
-
Pneumonia - atypical- 2 Qs (January 2023)
-
Post COVID syndrome - 4Qs (November 2022)
-
Post-infectious cough (November 2022)
-
Postoperative fever - 2Qs (January 2021)
-
Post-streptococcal glomerulonephritis - 2Qs (November 2021)
-
Preexposure prophylaxis in pregnancy (PrEP) (September 2019)
-
Preventing IV catheter infection - 2Qs (January 2022)
-
Prostatitis - 3Qs (July 2019)
-
Ramsay Hunt syndrome (November 2021)
-
Ramsay Hunt syndrome - 2Qs (March 2023)
-
Reactive arthritis (March 2020)
-
Refugee care (July 2019)
-
Respiratory Syncytial Virus - 2Qs (September 2019)
-
Rheumatic fever - acute - 3Qs (March 2022)
-
Rotavirus (July 2022)
-
Salmonella infection (September 2019)
-
Scalp lesions - 5Qs (September 2018)
-
Scarlet fever (March 2019)
-
Schistosomiasis - 2Qs (January 2020)
-
Screening for sexually transmitted infections - 4Qs (July 2022)
-
Sinusitis - complications (November 2019)
-
Soft Tissue Infections - 9 Qs (September 2022)
-
Spontaneous bacterial peritonitis - 2Qs (March 2020)
-
Streptococcal pharyngitis in children (November 2020)
-
Surgical site infections (March 2023)
-
Syphilis - 3Qs (September 2019)
-
Syphilis - Congenital - 3Qs (September 2018)
-
Syphilis in pregnancy - 2Qs (January 2022)
-
Syphilis testing - 4Qs (March 2022)
-
Tertiary syphilis - 2Qs (January 2022)
-
Tick paralysis (November 2020)
-
Travel and polio - 2Qs (January 2020)
-
Trichomoniasis - 2Qs (March 2022)
-
Trichomoniasis (March 2020)
-
Tuberculosis - extrapulmonary - 3Qs (January 2019)
-
Tuberculosis in pregnancy (March 2019)
-
Tuberculosis - latent infection - 2Qs (May 2020)
-
Tuberculosis testing - 2Qs (September 2018)
-
Tularemia - 2Qs (September 2019)
-
Upper respiratory tract infection - treatment - 2Qs (January 2021)
-
Urethritis (July 2022)
-
UTI in children (March 2021)
-
Varicella zoster vaccine (March 2023)
-
Vulvovaginal candidiasis in pregnancy (UPDATED) (September 2019)
-
Vulvovaginal Candidiasis in pregnancy (September 2018)
-
Yellow fever (March 2023)
-
Yellow fever - 2Qs (September 2019)
-
Zika infection (January 2019)
-
Zika syndrome - Congenital (January 2019)
-
About this course
- Free
- 218 lessons
- 0 hours of video content